Dube Michael P
VP, Chief Accounting Officer · 5 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | NTLA | Intellia Therapeutics, Inc. | Sale | 2,641 | $16.78 | $44,315.98 | filing |
| 2026-03-01 | NTLA | Intellia Therapeutics, Inc. | Award | 17,250 | $0.00 | $0.00 | filing |
| 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Sale | 2,989 | $9.21 | $27,528.69 | filing |
| 2025-10-01 | NTLA | Intellia Therapeutics, Inc. | Sale | 1,871 | $17.38 | $32,517.98 | filing |
| 2025-07-02 | NTLA | Intellia Therapeutics, Inc. | Sale | 2,503 | $9.95 | $24,904.85 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.